Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation

Journal of Arrhythmia
Daiki ShimomuraSeiji Kawano

Abstract

Activated partial thromboplastin time (aPTT) is recommended for monitoring anticoagulant activity in dabigatran-treated patients; however, there are limited data in Japanese patients. To clarify the relationship between plasma dabigatran concentration and aPTT, we analyzed plasma dabigatran concentration and aPTT at various time points following administration of oral dabigatran in a Japanese hospital. We enrolled 149 patients (316 blood samples) with non-valvular atrial fibrillation (NVAF) who were taking dabigatran. Patients had a mean age of 66.6±10.0 years (range: 35-84) and 66% were men. Plasma dabigatran concentrations and aPTT were measured using the Hemoclot(®) direct thrombin inhibitor assay and Thrombocheck aPTT-SLA(®), respectively. Samples were classified into eight groups according to elapsed times in hours since oral administration of dabigatran. Significantly higher dabigatran concentrations were observed in samples obtained from patients with low creatinine clearance (CLCr) (CLCr<50 mL/min). Dabigatran concentrations and aPTT were highest in the 4-h post-administration range. Additionally, there was a significant correlation between plasma dabigatran concentrations and aPTT (y=0.063x+32.596, r (2)=0.648, p<0.001...Continue Reading

References

Aug 22, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Joachim Stangier, Andreas Clemens
Nov 26, 2010·Thrombosis and Haemostasis·Tomas L LindahlUNKNOWN Expert Group on Coagulation of the External Quality Assurance in Laboratory Medicine in Sweden
Mar 26, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Masatsugu HoriUNKNOWN RE-LY Investigators
Jan 10, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Joachim Stangier, Martin Feuring
Feb 2, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinya SuzukiTakeshi Yamashita
Apr 30, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelUNKNOWN European Heart Rhythm Association
May 18, 2013·Journal of cardiology·Mihoko KawabataKenzo Hirao
Jun 21, 2013·European Journal of Clinical Pharmacology·Jovan P AntovicRickard E Malmström

❮ Previous
Next ❯

Citations

Feb 14, 2018·Basic & Clinical Pharmacology & Toxicology·Stine Marie HavigGudrun Høiseth
Dec 3, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Lianfang NiZhijie Zhao
Jan 28, 2020·Journal of the Neurological Sciences·Shinichi WadaMasatoshi Koga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.